Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BDPTBIOADAPTIVES, INC.

OTC · CIK 0001575142
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts310

Identity from submissions API

NameBIOADAPTIVES, INC.
CIK0001575142
TickersBDPT
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN462592228
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(702) 659-8829
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • APEX 8 Inc. (2013-05-03T04:00:00.000Z → 2013-08-19T04:00:00.000Z)
Business address
2620 REGATTA DRIVE
SUITE 102
LAS VEGAS
NV
89128
NV
Mailing address
2620 REGATTA DRIVE
SUITE 102
LAS VEGAS
NV
89128
NV

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

177 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q FORM 10-Q 0001640334-26-001821 000-54949 261560614 34 4083185 1 1
2026-11-04 4 FORM 4 0001640334-26-001738 6495
2026-11-04 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001640334-26-001712 000-54949 261519808 34 557243 1 1
2026-10-06 4 FORM 4 0001640334-26-001616 6532
2026-09-03 4 FORM 4 0001640334-26-001451 6536
2026-08-19 10-Q FORM 10-Q 0001640334-26-001393 000-54949 261293880 34 4257449 1 1
2026-08-14 NT 10-Q FORM NT 10-Q 0001640334-26-001379 000-54949 261283841 34 27836
2026-08-04 4 FORM 4 0001640334-26-001262 6536
2026-07-06 4 FORM 4 0001640334-26-001151 6535
2026-06-03 4 xslF345X06/e665037_4-bdpt.xml 0001193805-26-000750 6642
2026-05-15 10-Q FORM 10-Q 0001640334-26-000911 000-54949 26987789 34 3446599 1 1
2026-05-05 4 FORM 4 0001640334-26-000829 6532
2026-04-14 10-K FORM 10-K 0001640334-26-000718 000-54949 26860868 34 4647863 1 1
2026-04-03 4 FORM 4 0001640334-26-000637 6553
2026-03-31 NT 10-K FORM NT 10-K 0001640334-26-000599 000-54949 26821645 34 33101
2026-03-03 4 FORM 4 0001640334-26-000388 6428
2026-02-03 4 FORM 4 0001640334-26-000209 6428
2026-01-05 4 FORM 4 0001640334-26-000020 6428
2025-12-03 4 xslF345X05/e665037_4-bdpt.xml 0001193805-25-001712 6505
2025-11-14 10-Q FORM 10-Q 0001640334-25-002081 000-54949 251480762 34 3936227 1 1
2025-11-04 4 xslF345X05/e664940_4-bdpt.xml 0001193805-25-001528 6505
2025-10-06 4 xslF345X05/e664883_4-bdpt.xml 0001193805-25-001409 6504
2025-09-03 4 xslF345X05/e664816_4-bdpt.xml 0001193805-25-001252 6474
2025-08-14 10-Q FORM 10-Q 0001640334-25-001493 000-54949 251217944 34 3717232 1 1
2025-08-05 4 xslF345X05/e664765_4-bdpt.xml 0001193805-25-001159 6474
2025-07-03 4 xslF345X05/e664676_4-bdpt.xml 0001193805-25-000978 6472
2025-06-03 4 xslF345X05/e664583_4-bdpt.xml 0001193805-25-000773 6472
2025-05-23 4 xslF345X05/e664546_4-bdpt.xml 0001193805-25-000716 6471
2025-05-13 10-Q FORM 10-Q 0001640334-25-000834 000-54949 25939973 34 3038972 1 1
2025-05-05 4 xslF345X05/e664474_4-bdpt.xml 0001193805-25-000608 16326
2025-05-05 3 xslF345X02/e664473_3-bdpt.xml 0001193805-25-000607 4930
2025-04-15 10-K FORM 10-K 0001640334-25-000660 000-54949 25840594 34 4572333 1 1
2025-03-31 NT 10-K FORM NT 10-K 0001640334-25-000559 000-54949 25794791 34 32232
2025-03-28 DEF 14C DEF 14C 0001640334-25-000527 000-54949 25787954 34 61356
2025-03-18 8-K FORM 8-K 7.01,9.01 0001640334-25-000428 000-54949 25745999 34 156698 1 1
2025-03-14 DEF 14C DEF 14C 0001640334-25-000388 000-54949 25741043 34 70914
2025-02-24 SEC STAFF ACTION filename1.pdf 9999999997-25-000549 3874
2025-02-07 8-K FORM 8-K 5.02,9.01 0001640334-25-000210 000-54949 25602446 34 184890 1 1
2024-12-05 8-K FORM 8-K 7.01,9.01 0001640334-24-001825 000-54949 241527684 34 155293 1 1
2024-12-03 4 FORM 4 0001640334-24-001815 4600
2024-11-27 8-K FORM 8-K 7.01,9.01 0001640334-24-001796 000-54949 241505726 34 156461 1 1
2024-11-20 8-K FORM 8-K 7.01,8.01,9.01 0001640334-24-001769 000-54949 241481247 34 183825 1 1
2024-11-19 10-Q FORM 10-Q 0001640334-24-001752 000-54949 241472742 34 3523675 1 1
2024-11-14 NT 10-Q NT 10-Q 0001640334-24-001727 000-54949 241462063 34 37022
2024-10-30 8-K FORM 8-K 7.01,8.01,9.01 0001640334-24-001612 000-54949 241407115 34 167557 1 1
2024-10-22 SC 13D FORM SC 13D 0001640334-24-001555 005-89233 241385338 34 61719
2024-10-22 SC 13D SC 13D 0001640334-24-001554 005-89233 241385333 34 60613
2024-08-19 10-Q FORM 10-Q 0001640334-24-001302 000-54949 241218460 34 3213813 1 1
2024-08-15 NT 10-Q NT 10-Q 0001640334-24-001274 000-54949 241211504 34 35815
2024-05-22 8-K FORM 8-K 5.02,7.01,9.01 0001640334-24-000864 000-54949 24971557 34 163713 1 1
2024-05-17 10-Q FORM 10-Q 0001640334-24-000843 000-54949 24959744 34 2916512 1 1
2024-05-15 NT 10-Q NT 10-Q 0001640334-24-000800 000-54949 24951089 34 30885
2024-05-14 8-K FORM 8-K 4.01 0001640334-24-000767 000-54949 24941055 34 150041 1 1
2024-04-10 10-K FORM 10-K 0001640334-24-000602 000-54949 24834802 34 4050163 1 1
2024-04-01 NT 10-K NT 10-K 0001640334-24-000547 000-54949 24811129 34 31941
2023-11-13 10-Q FORM 10-1Q 0001640334-23-002105 000-54949 231398656 34 3413651 1 1
2023-10-11 1-A xsl1-A_X01/primary_doc.xml 0001477932-23-007567 024-12338 231320670 33 20251024
2023-08-24 1-Z xsl1-Z_X01/primary_doc.xml 0001640334-23-001624 24R-00894 231201510 33 3708
2023-08-11 10-Q FORM 10-Q 0001640334-23-001531 000-54949 231164348 34 3004286 1 1
2023-05-12 10-Q FORM 10-Q 0001640334-23-000837 000-54949 23914681 34 2792756 1 1
2023-04-06 8-K FORM 8-K 5.02,5.03,9.01 0001640334-23-000587 000-54949 23804308 34 462781 1 1
2023-03-31 10-K FORM 10-K 0001640334-23-000532 000-54949 23787264 34 3945326 1 1
2023-03-28 DEF 14C DEF 14C 0001640334-23-000456 000-54949 23766066 34 69279
2023-03-09 PRE 14C PRE14C 0001640334-23-000309 000-54949 23717508 34 60811
2022-11-17 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-22-000442 024-11819 221400457 33 1794
2022-11-15 CORRESP filename1.htm 0001477932-22-008657 8703
2022-11-14 10-Q FORM 10-Q 0001640334-22-002451 000-54949 221385891 34 3273902 1 1
2022-11-08 1-A POS xsl1-A_X01/primary_doc.xml 0001477932-22-008207 024-11819 221366930 33 1329768
2022-10-31 UPLOAD filename1.pdf 0000000000-22-011852 43916
2022-10-28 CORRESP filename1.htm 0001477932-22-008007 423683
2022-10-28 1-A POS xsl1-A_X01/primary_doc.xml 0001477932-22-008006 024-11819 221340185 33 1319317
2022-10-20 UPLOAD filename1.pdf 0000000000-22-011567 43855
2022-10-07 1-A POS xsl1-A_X01/primary_doc.xml 0001477932-22-007505 024-11819 221301419 33 936387
2022-08-12 10-Q FORM 10-Q 0001640334-22-001749 000-54949 221159381 34 3269854 1 1
2022-06-14 8-K FORM 8-K 7.01,9.01 0001640334-22-001241 000-54949 221014021 34 178747 1 1
2022-05-16 253G1 FORM 253G1 0001640334-22-001009 024-11819 22925152 33 846084
2022-05-12 10-Q FORM 10-Q 0001640334-22-000978 000-54949 22919148 34 3029614 1 1
2022-05-11 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-22-000178 024-11819 22915490 33 1743
2022-05-09 CORRESP filename1.htm 0001640334-22-000923 13121
2022-05-03 1-A/A xsl1-A_X01/primary_doc.xml 0001640334-22-000879 024-11819 22884008 33 892660
2022-03-31 10-K FORM 10-K 0001640334-22-000689 000-54949 22794316 34 4009646 1 1
2022-03-30 UPLOAD filename1.pdf 0000000000-22-003436 44181
2022-03-18 1-A/A xsl1-A_X01/primary_doc.xml 0001640334-22-000529 024-11819 22751518 33 1303628
2022-03-16 UPLOAD filename1.pdf 0000000000-22-002910 46023
2022-03-15 DEF 14C FORM 14C 0001640334-22-000502 000-54949 22742307 34 59053
2022-03-04 1-A xsl1-A_X01/primary_doc.xml 0001640334-22-000421 024-11819 22711488 33 5260732
2022-02-03 8-K FORM 8-K 1.01,7.01,9.01 0001640334-22-000252 000-54949 22589392 34 253704 1 1
2022-01-27 PRE 14C PRE 14C 0001640334-22-000184 000-54949 22559145 34 68370
2022-01-21 8-K FORM 8-K 7.01,9.01 0001640334-22-000150 000-54949 22544066 34 159973 1 1
2021-12-16 8-K FORM 8-K 7.01,9.01 0001640334-21-003192 000-54949 211495905 34 168736 1 1
2021-11-10 10-Q FORM 10-Q 0001640334-21-002736 000-54949 211395713 34 3246385 1 1
2021-08-27 8-K FORM 8-K 7.01,9.01 0001640334-21-002041 000-54949 211213475 34 157223 1 1
2021-08-12 10-Q FORM 10-Q 0001640334-21-001817 000-54949 211165217 34 3052003 1 1
2021-07-22 8-K FORM 8-K 8.01,9.01 0001640334-21-001630 000-54949 211107698 34 32652
2021-06-11 8-K FORM 8-K 1.01,5.02,7.01,9.01 0001640334-21-001330 000-54949 211009897 34 284923
2021-05-14 10-Q FORM 10-Q 0001640334-21-001151 000-54949 21924306 34 2236313 1
2021-03-30 10-K FORM 10-K 0001640334-21-000706 000-54949 21788331 34 2908445 1
2020-11-16 10-Q FORM 10-Q 0001640334-20-002835 000-54949 201315705 34 2237524 1
2020-08-13 10-Q FORM 10-Q 0001640334-20-002076 000-54949 201098892 34 2144385 1
2020-06-16 8-K FORM 8-K 8.01,9.01 0001640334-20-001539 000-54949 20966178 34 28345
2020-06-11 10-Q/A FORM 10-Q AMENDMENT NO. 1 0001640334-20-001483 000-54949 20956229 34 2172128 1
2020-06-10 10-Q FORM 10-Q 0001640334-20-001468 000-54949 20955481 34 970227 1
2020-05-12 10-K/A FORM 10-K/A 0001640334-20-001156 000-54949 20868396 34 2763670 1
2020-05-11 8-K FORM 8-K 8.01 0001640334-20-001137 000-54949 20864406 34 34769
2020-05-01 10-K FORM 10-K 0001640334-20-000974 000-54949 20837901 34 2830543 1
2020-03-30 8-K FORM 8-K 8.01 0001640334-20-000664 000-54949 20756379 34 35140
2020-03-04 DEF 14C DEF 14C 0001640334-20-000452 000-54949 20685620 34 82534
2020-02-11 8-K FORM 8-K 3.03,5.03,9.01 0001640334-20-000235 000-54949 20593374 34 697199
2020-02-10 PRE 14C PRE 14C 0001640334-20-000219 000-54949 20589090 34 77244
2019-11-07 10-Q FORM 10-Q 0001640334-19-002191 000-54949 191197591 34 2306893 1
2019-09-27 8-K CURRENT EVENT REPORT - FORM 8-K 5.02,8.01,9.01 0001376474-19-000240 000-54949 191121711 34 37386
2019-08-14 10-Q FORM 10-Q 0001640334-19-001635 000-54949 191025590 34 2264843 1
2019-08-01 UPLOAD filename1.pdf 0000000000-19-011936 45579
2019-07-23 10-12G/A 10-12G/A 0001640334-19-001437 000-54949 19966927 34 1538931
2019-07-10 UPLOAD filename1.pdf 0000000000-19-010912 50667
2019-06-27 10-12G/A 10-12G/A 0001640334-19-001256 000-54949 19926356 34 1547635
2019-06-06 UPLOAD filename1.pdf 0000000000-19-009530 57628
2019-05-10 10-12G 10-12G 0001640334-19-000808 000-54949 19814164 34 471085
2017-03-31 15-15D 15-15D 0001640334-17-000603 333-192619 17727636 34 10066
2016-11-18 10-Q FORM 10-Q 0001640334-16-002064 000-54949 162008406 34 1338415 1
2016-11-15 NT 10-Q NT 10-Q 0001640334-16-002003 000-54949 161997186 34 20104
2016-08-18 10-Q 10-Q 0001640334-16-001576 000-54949 161840806 34 1306829 1
2016-08-16 NT 10-Q FORM 12B-25 0001640334-16-001568 000-54949 161835865 34 28427
2016-05-23 10-Q FORM 10-Q 0001640334-16-001141 000-54949 161668429 34 1479440 1
2016-05-17 NT 10-Q FORM 12B-25 0001640334-16-001104 000-54949 161655945 34 28426
2016-04-14 10-K FORM 10-K 0001640334-16-000961 000-54949 161572617 34 2330883 1
2016-03-31 NT 10-K FORM 12B-25 0001640334-16-000896 000-54949 161542792 34 27862
2016-01-05 3 PRIMARY DOCUMENT 0001520631-16-000012 4427
2016-01-05 SC 13D/A SC 13D/A 0001262463-16-000798 005-89233 161320639 34 28614
2016-01-05 SC 13D SC 13D 0001262463-16-000797 005-89233 161320638 34 29931
2015-11-23 10-Q FORM 10-Q 0001640334-15-000365 000-54949 151249464 34 1545351 1
2015-11-16 NT 10-Q FORM 12B-25 0001640334-15-000333 000-54949 151234133 34 28392
2015-08-21 10-Q QUARTERLY REPORT 0001213900-15-006479 000-54949 151069479 34 1261812 1
2015-08-14 NT 10-Q NT 10-Q 0001213900-15-006143 000-54949 151054679 34 30009
2015-05-20 10-Q QUARTERLY REPORT 0001213900-15-004050 000-54949 15879440 34 1808463 1
2015-05-18 NT 10-Q NT 10-Q 0001213900-15-003956 000-54949 15873443 34 36452
2015-04-23 8-K FORM 8-K 4.01,9.01 0001262463-15-000289 000-54949 15787890 34 42775
2015-04-15 10-K FORM 10-K 0001262463-15-000273 000-54949 15771382 34 2018920 1
2015-03-31 NT 10-K NT 10-K 0001262463-15-000239 000-54949 15738893 34 32977
2015-02-06 8-K FORM 8-K 5.02,9.01 0001262463-15-000064 000-54949 15583522 34 143384
2014-11-14 10-Q FORM 10-Q 0001262463-14-001086 000-54949 141223619 34 1789135 1
2014-08-14 10-Q FORM 10-Q 0001262463-14-000773 000-54949 141044309 34 1547835 1
2014-07-15 8-K FORM 8-K 5.02,8.01,9.01 0001262463-14-000608 000-54949 14976049 34 25699
2014-07-10 8-K FORM 8-K. 8.01,9.01 0001262463-14-000600 000-54949 14969006 34 22833
2014-05-23 8-K FORM 8-K 1.01,4.01,9.01 0001262463-14-000498 000-54949 14865636 34 56298
2014-05-20 10-Q/A FORM 10-Q 0001262463-14-000495 000-54949 14858882 34 204127
2014-05-20 10-Q FORM 10-Q 0001262463-14-000490 000-54949 14856839 34 1222313 1
2014-05-15 NT 10-Q NT 10-Q 0001262463-14-000441 000-54949 14844830 34 33135
2014-04-14 10-K FORM 10-K 0001262463-14-000296 000-54949 14761869 34 1864866 1
2014-03-28 NT 10-K NT 10-K 0001262463-14-000220 000-54949 14726774 34 33059
2014-03-07 424B3 424B3 0001262463-14-000157 333-192619 14674267 33 555520
2014-01-17 4 FORM 4 0001262463-14-000057 4746
2014-01-17 4 FORM 4 0001262463-14-000055 4653
2014-01-14 424B3 424B3 0001262463-14-000054 333-192619 14527773 33 550087
2014-01-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2014-01-10 15:00:00 9999999995-14-000095 333-192619 14523102 33 1782
2014-01-07 S-1/A FORM S-1 0001262463-14-000020 333-192619 14512545 33 1345340 1
2013-12-02 S-1 FORM S-1 0001262463-13-000814 333-192619 131250508 33 1337158 1
2013-10-25 8-K FORM 8-K 1.01,2.01,3.02,5.01,5.06,9.01 0001262463-13-000705 000-54949 131171458 34 600353
2013-10-21 10-Q FORM 10-Q 0001262463-13-000696 000-54949 131161452 34 912185 1
2013-10-08 8-K FORM 8-K 3.02 0001262463-13-000663 000-54949 131140093 34 12329
2013-10-08 D xslFormDX01/primary_doc.xml 06b 0001262463-13-000661 021-204166 131140091 33 5830
2013-09-30 8-K FORM 8-K 5.03,5.07,9.01 0001262463-13-000648 000-54949 131123942 34 20484
2013-08-19 UPLOAD filename1.pdf 0000000000-13-045609 36071
2013-08-13 3 FORM 3 0001262463-13-000530 3637
2013-08-13 3 FORM 3 0001262463-13-000529 3816
2013-08-13 10-Q FORM 10-Q 0001262463-13-000523 000-54949 131031131 34 950161 1
2013-08-06 CORRESP filename1.htm 0001262463-13-000495 12457
2013-08-06 8-K/A FORM 8-K/A 5.01,5.02 0001262463-13-000494 000-54949 131012242 34 57191
2013-07-23 3 FORM 3 0001262463-13-000475 3434
2013-07-23 UPLOAD filename1.pdf 0000000000-13-040202 157195
2013-07-05 8-K FORM 8-K 5.01,5.02 0001262463-13-000452 000-54949 13954400 34 25781
2013-07-03 4 OWNERSHIP DOCUMENT 0001262463-13-000453 4384
2013-06-11 UPLOAD filename1.pdf 0000000000-13-031839 33575
2013-05-31 UPLOAD filename1.pdf 0000000000-13-029726 158075
2013-05-31 CORRESP filename1.htm 0001262463-13-000345 15976
2013-05-31 10-12G/A FORM 10 0001262463-13-000344 000-54949 13883480 34 328645
2013-05-03 10-12G FORM 10 0001262463-13-000249 000-54949 13812252 34 725416

Latest XBRL company facts

One latest value per concept from companyfacts (310 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 223.68M 2026-11-06 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
dei EntityPublicFloat Entity Public Float USD 252,181 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 292,190 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 324,921 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap AccountsPayableAndAccruedLiabilitiesFairValueDisclosure Accounts Payable and Accrued Liabilities, Fair Value Disclosure USD 25,361 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 292,190 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3,344 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 7,701 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 0.04 2024-12-31 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 32,135 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 59 2025-09-30 2025 Q3 10-Q 2025-11-14 0001640334-25-002081
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 179 2020-03-31 2020 Q1 10-Q/A 2020-06-11 0001640334-20-001483
us-gaap AccountsReceivableSale Accounts Receivable, Sale USD 3,344 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 254,098 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 1,003 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap AccruedRentCurrent Accrued Rent, Current USD 38,861 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap AccruedRentCurrentAndNoncurrent Accrued Rent USD 21,762 2015-09-30 2015 Q3 10-Q 2015-11-23 0001640334-15-000365
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 241,666 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2,500 2025-09-30 2025 Q3 10-Q 2025-11-14 0001640334-25-002081
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -58,631 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 9.52M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 3.87M 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap AdjustmentForAmortization Amortization USD 61,464 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001640334-22-002451
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 52,365 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 10,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 28,670 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5,429 2022-04-01 2022-06-30 2022 Q3 10-Q 2022-11-14 0001640334-22-002451
us-gaap AdvertisingExpense Advertising Expense USD 89,428 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 49,692 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 236,453 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 216,931 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001640334-26-000911
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.29B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap Assets Assets USD 57,506 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AssetsCurrent Assets, Current USD 48,006 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 2,908 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) USD -25,271 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 25,271 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap BankOverdrafts Bank Overdrafts USD 743 2019-09-30 2019 Q3 10-Q 2019-11-07 0001640334-19-002191
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 200,000 2013-04-19 2014-03-31 2014 Q1 10-Q 2014-05-20 0001262463-14-000490
us-gaap Cash Cash USD 49,517 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001749
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 22,210 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 215,205 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -44,349 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5,144 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -153,301 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -57,531 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001640334-23-000532
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 82,936 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 61,752 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.1 2019-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 200,000 2019-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 66 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.25B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 223.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 223.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 362,390 2019-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 5,885 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CommonStockValue Common Stock, Value, Issued USD 22,367 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -142,398 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 202,643 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 206.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 443.21M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0001640334-24-000602
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 515,887 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 515,887 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1,824 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap CostOfRevenue Cost of Revenue USD 3,128 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap CreditCardReceivables Credit Card Receivables USD 0 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 24,380 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-13 0001640334-20-002076
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 206.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 282,112 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0001640334-24-000602
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 75,650 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001749
us-gaap DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal Debt Instrument, Convertible, If-converted Value in Excess of Principal USD 79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 10,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 69,878 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.04 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 902 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 210,613 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 205,000 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 31,665 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap DeferredCompensationArrangementWithIndividualCompensationExpense Deferred Compensation Arrangement with Individual, Compensation Expense USD 210,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 51,079 2014-09-30 2014 Q3 10-Q 2014-11-14 0001262463-14-001086
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 4,570 2013-12-31 2013 FY 10-K 2014-04-14 0001262463-14-000296
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 919,097 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 919,097 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 3,177 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1,700 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap Depreciation Depreciation USD 4,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DerivativeFairValueHedgeIncludedInEffectivenessGainLoss Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss) USD -174,884 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001640334-26-000911
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 94,200 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001749
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 798,637 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 266,222 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001640334-20-002835
us-gaap DerivativeLiabilities Derivative Liability USD 1.86M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.86M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 120,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 147,567 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 272,581 2014-06-30 2014 Q2 10-Q 2014-08-14 0001262463-14-000773
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 77,715 2020-12-31 2020 FY 10-K 2021-03-30 0001640334-21-000706
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.03 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.21 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 42,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 63 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001749
us-gaap EstimateOfCancellations Estimate of Cancellations USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 456,003 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -8,644 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap FeeIncome FeeIncome USD 5,000 2024-11-01 2024-11-30 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 24,500 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 0 2024-03-31 2024 Q1 10-Q 2024-05-17 0001640334-24-000843
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 7,875 2024-03-31 2024 Q1 10-Q 2024-05-17 0001640334-24-000843
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 3,000 2024-03-31 2024 Q1 10-Q 2024-05-17 0001640334-24-000843
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 7,125 2024-03-31 2024 Q1 10-Q 2024-05-17 0001640334-24-000843
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 24,500 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 578,645 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 32,000 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap GainLossOnSaleOfAccountsReceivable Gain (Loss) on Sale of Accounts Receivable USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001640334-21-001151
us-gaap GainLossOnSaleOfLeasedAssetsNetOperatingLeases Gain (Loss) on Sale of Leased Assets, Net, Operating Leases USD 4.40M 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001640334-22-002451
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 376,948 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 594,387 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 18,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap GrossProfit Gross Profit USD 12,367 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 81,350 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ImpairmentOfRealEstate Impairment of Real Estate USD 18,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -197,136 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0001640334-25-000834
us-gaap IncomeLossFromSubsidiariesBeforeTax Income (Loss) from Subsidiaries, before Tax USD -1.05M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -270,108 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001640334-21-000706
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -77,327 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 89,693 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 129,343 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 13,500 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD 133,334 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001640334-22-002451
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 51,079 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-23 0001640334-15-000365
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 2,500 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-23 0001640334-16-001141
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -1,700 2013-04-19 2013-12-31 2014 FY 10-K 2015-04-15 0001262463-15-000273
us-gaap IncreaseDecreaseInDerivativeAssetsAndLiabilities Increase (Decrease) in Derivative Assets and Liabilities USD 162,755 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 185,291 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-17 0001640334-24-000843
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 2,978 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -10,509 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 1,000 2013-04-19 2013-09-30 2013 Q3 10-Q 2013-10-21 0001262463-13-000696
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0001640334-25-000834
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2,415 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -1,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 14,000 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap InterestExpense Interest Expense USD 961 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestExpenseDebt Interest Expense, Debt USD 112,321 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 349,735 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestExpenseOther Interest Expense, Other USD 931 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 156 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap InterestExpenseTimeDeposits Interest Expense, Time Deposits USD 600 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 48,912 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 317 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001640334-26-000911
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4,319 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestPayableCurrent Interest Payable, Current USD 257,274 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 74,551 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 24,865 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InventoryNet Inventory, Net USD 34,197 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 9,332 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap InventoryWriteDown Inventory Write-down USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap InvestmentOwnedBalancePrincipalAmount Investment Owned, Balance, Principal Amount USD 27,715 2020-12-31 2020 FY 10-K 2021-03-30 0001640334-21-000706
us-gaap InvestmentOwnedBalanceShares Investment Owned, Balance, Shares shares 1.06M 2014-12-31 2014 FY 10-K 2015-04-15 0001262463-15-000273
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 102,500 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001640334-21-001151
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-30 0001640334-21-000706
us-gaap Liabilities Liabilities USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 57,506 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap LitigationSettlementGain LitigationSettlementGain USD 73,772 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap LoansPayableCurrent Loans Payable, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-30 0001640334-21-000706
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD -127 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001640334-22-001749
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -138,462 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2013-09-11 2015 Q3 10-Q 2015-11-23 0001640334-15-000365
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 89,454 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -242,755 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -533,698 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap NoncashOrPartNoncashAcquisitionInventoryAcquired1 Noncash or Part Noncash Acquisition, Inventory Acquired USD 144,402 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued shares 200,000 2013-04-19 2013-12-31 2014 FY 10-K 2015-04-15 0001262463-15-000273
us-gaap NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1 Nondebtor Reorganization Items, Net (Gain) Loss on Settlement of Other Claims USD -51,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001640334-21-001151
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -445,320 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001640334-20-002835
us-gaap NotesIssued1 Notes Issued USD 32,096 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NotesPayable Notes Payable USD 32,096 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap NotesPayableCurrent Notes Payable, Current USD 32,096 2024-09-30 2024 Q3 10-Q 2024-11-19 0001640334-24-001752
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 10,246 2023-03-31 2023 Q1 10-Q 2023-05-12 0001640334-23-000837
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 8,444 2023-03-31 2023 Q1 10-Q 2023-05-12 0001640334-23-000837
us-gaap OperatingExpenses Operating Expenses USD 700,259 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -687,892 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 1,500 2014-05-31 2014-06-01 2015 Q2 10-Q 2015-08-21 0001213900-15-006479
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 200,260 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 200,260 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2,781 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -106 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001262463-14-000773
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -1,956 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1,956 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap OtherExpenses Other Expenses USD 413,867 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap OtherIncome Other Income USD 5 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001640334-26-000911
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001640334-25-002081
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -2,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -771,419 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap OtherReceivables Other Receivables USD 0 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap PaymentsForRepurchaseOfRedeemablePreferredStock Payments for Repurchase of Redeemable Preferred Stock USD 75,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 1,582 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap PreferredStockRedemptionDiscount Preferred Stock Redemption Discount USD 193,500 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 31.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001640334-21-001817
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001640334-21-001817
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 110 2021-06-30 2021 Q2 10-Q 2021-08-12 0001640334-21-001817
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8,665 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 51,079 2014-01-01 2014-12-31 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 749 2013-04-19 2014-03-31 2014 Q1 10-Q 2014-05-20 0001262463-14-000490
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 749 2013-04-19 2013-12-31 2013 FY 10-K 2014-04-14 0001262463-14-000296
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 239,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ProceedsFromIssuanceOfTrustPreferredSecurities Proceeds from Issuance of Trust Preferred Securities USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001640334-23-000837
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ProceedsFromRepaymentsOfBankOverdrafts Proceeds from (Repayments of) Bank Overdrafts USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001640334-20-002835
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 32,000 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 32,000 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap ProfessionalFees Professional Fees USD 101,372 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 39,004 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001640334-25-002081
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 9,500 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 19,381 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 149,546 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 860 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 20,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 860 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -12.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 6,703 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap Revenues Revenues USD 15,495 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap SalariesWagesAndOfficersCompensation Salary and Wage, Excluding Cost of Good and Service Sold USD 118,333 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 11,944 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-18 0001640334-16-002064
us-gaap SecurityDeposit Security Deposit USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap SeparateAccountLiabilityPeriodIncreaseDecrease SeparateAccountLiabilityPeriodIncreaseDecrease USD 150,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 410,999 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 2.35 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001640334-24-001302
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 2.94 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 2.31 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.013 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-19 0001640334-24-001302
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.055 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.053 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001640334-25-000660
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 200,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-16 0001640334-20-002835
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap SharePrice Share Price USD/shares 3.65 2014-04-10 2015 FY 10-K 2016-04-14 0001640334-16-000961
us-gaap StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition Standard Product Warranty Accrual, Additions from Business Acquisition USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0001640334-24-000602
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 20,528 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001640334-22-000689
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -2.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssued1 Stock Issued USD 139,150 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 211.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 5.76M 2021-06-29 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 438,663 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 139,150 2018-01-01 2018-12-31 2019 FY 10-K/A 2020-05-12 0001640334-20-001156
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 5,000 2013-04-19 2013-12-31 2013 FY 10-K 2014-04-14 0001262463-14-000296
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 13,500 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 16,500 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-10 0001640334-24-000602
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 200,000 2013-04-19 2013-12-31 2014 FY 10-K 2015-04-15 0001262463-15-000273
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 8,999 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 0.006 2022-02-01 2022-02-06 2023 Q2 10-Q 2023-08-11 0001640334-23-001531
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 28,670 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-14 0001640334-26-000718
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 35 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0001640334-22-000978
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -2,284 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001640334-19-001635
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 267.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 280.11M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001640334-26-001393
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 31.69M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001640334-21-002736
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 482.80M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001640334-23-002105
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 64.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001640334-26-001821

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →